Contact

biotechnology

biotechnology

We are together in each step
Array ( [0] => WP_Term Object ( [term_id] => 964 [name] => BGI-Shenzhen [slug] => bgi-shenzhen [term_group] => 0 [term_taxonomy_id] => 964 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [1] => WP_Term Object ( [term_id] => 238 [name] => biotechnology [slug] => biotechnology [term_group] => 0 [term_taxonomy_id] => 238 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 23 [filter] => raw ) [2] => WP_Term Object ( [term_id] => 417 [name] => e-health [slug] => e-health [term_group] => 0 [term_taxonomy_id] => 417 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 8 [filter] => raw ) [3] => WP_Term Object ( [term_id] => 965 [name] => Freenome [slug] => freenome [term_group] => 0 [term_taxonomy_id] => 965 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [4] => WP_Term Object ( [term_id] => 966 [name] => genes [slug] => genes [term_group] => 0 [term_taxonomy_id] => 966 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [5] => WP_Term Object ( [term_id] => 967 [name] => genetica [slug] => genetica [term_group] => 0 [term_taxonomy_id] => 967 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [6] => WP_Term Object ( [term_id] => 968 [name] => genomica [slug] => genomica [term_group] => 0 [term_taxonomy_id] => 968 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [7] => WP_Term Object ( [term_id] => 153 [name] => global corporate finance [slug] => global-corporate-finance [term_group] => 0 [term_taxonomy_id] => 153 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 613 [filter] => raw ) [8] => WP_Term Object ( [term_id] => 969 [name] => GRAIL [slug] => grail [term_group] => 0 [term_taxonomy_id] => 969 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [9] => WP_Term Object ( [term_id] => 970 [name] => Guardant Health [slug] => guardant-health [term_group] => 0 [term_taxonomy_id] => 970 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [10] => WP_Term Object ( [term_id] => 971 [name] => inbiomotion [slug] => inbiomotion [term_group] => 0 [term_taxonomy_id] => 971 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [11] => WP_Term Object ( [term_id] => 972 [name] => kanteron [slug] => kanteron [term_group] => 0 [term_taxonomy_id] => 972 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [12] => WP_Term Object ( [term_id] => 202 [name] => M&A [slug] => ma [term_group] => 0 [term_taxonomy_id] => 202 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 37 [filter] => raw ) [13] => WP_Term Object ( [term_id] => 973 [name] => made-of-genes [slug] => made-of-genes [term_group] => 0 [term_taxonomy_id] => 973 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [14] => WP_Term Object ( [term_id] => 262 [name] => Minoryx [slug] => minoryx [term_group] => 0 [term_taxonomy_id] => 262 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 2 [filter] => raw ) [15] => WP_Term Object ( [term_id] => 974 [name] => Novogene [slug] => novogene [term_group] => 0 [term_taxonomy_id] => 974 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [16] => WP_Term Object ( [term_id] => 975 [name] => oryzon [slug] => oryzon [term_group] => 0 [term_taxonomy_id] => 975 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [17] => WP_Term Object ( [term_id] => 196 [name] => funding-round [slug] => funding-round [term_group] => 0 [term_taxonomy_id] => 196 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 59 [filter] => raw ) [18] => WP_Term Object ( [term_id] => 726 [name] => investment-round [slug] => investment-round [term_group] => 0 [term_taxonomy_id] => 726 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 15 [filter] => raw ) )
2017, a record year for global investment in Genomics with major funding rounds
Genomics investment in 2017 has already surpassed last year's figure, boosted by large rounds of funding, with the number of [...]
read more >>
The investment fund Columbus Venture Patners and Asklepios will invest up to €9M in the bio sector in Gipuzkoa.
The venture capital fund Columbus and the US company Asklepios set up the joint venture Viralgen to [...]
read more >>
Cancer biotechs receive funding: Immunostep and Dp Pharma
In the last month we have learned about two Spanish companies that focus their activity on the fight against cancer, Immunos [...]
read more >>
Ysios capital participates in $68M round in Kala pharmaceuticals
Ysios Capital, the leading private equity manager in the biotech sector in Spain, announced on 14 August that it has [...]
read more >>
Biotechnology is supported by investors.
Investment in biotechnology is booming so far this year, and several biotech companies are also investing in the biotech sector.
read more >>
Caixa Capital Risk invests in Inbiomotion
It seems that biotechnology is finding investors in our country. A few weeks ago we told you that Invere [...]
read more >>
Inveready bets on biotechnology, invests in Cuantum and AB-biotics in less than a month
Inveready has started the year with a strong commitment to biotechnology, if a few weeks ago we announced that it had invested in a [...]
read more >>
Oryzon genomics floats on the MAB
Oryzon Genomics is listed on the MAB, reinforcing the biotech market, which is the largest listed on the MAB. From [...]
read more >>
France's Synerlab buys Alcalá Pharma
If a week ago we told you that Spanish biotechs were coming out on the MAB, this week it is the turn of Spanish biotechs [...].
read more >>
Spanish biotechs go public
It is common for the biotech sector to be punished in the stock market on occasions because it has traditionally been [...]
read more >>
October 2015: Funding for the biotech sector: InnoUp Farma and Oryzon Genomics and Mind The Byte
In the second half of October we have witnessed that two Spanish companies focused on providing solutions for the [...]
read more >>
Investment analysis of Inveready
Inveready is one of the largest seed capital funds in our country, which was created in 2008, in the midst of the crisis and until now has been [...]
read more >>
closechevron-downcrossmenuchevron-down